Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval.
Burlington
D B
DB
Office of Drug Evaluation II, Food and Drug Administration, Rockville, Maryland 20857.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D004341:Drug Evaluation; D015507:Drugs, Investigational; D006801:Humans; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational